Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing | Zendy

Graham McIlroy | Zendy; Sarah Thomas | Zendy; Jamie J. Coleman | Zendy

Open Access

Second-generation antipsychotic drug use in hospital inpatients with dementia: the impact of a safety warning on rates of prescribing

Author(s) -

Graham McIlroy,

Sarah Thomas,

Jamie J. Coleman

Publication year - 2014

Publication title -

journal of public health

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.916

H-Index - 82

eISSN - 1741-3850

pISSN - 1741-3842

DOI - 10.1093/pubmed/fdu023

Subject(s) - medicine , dementia , antipsychotic , drug , psychiatry , antipsychotic drug , public health , epidemiology , medical emergency , emergency medicine , schizophrenia (object oriented programming) , nursing , disease

Behavioural and psychological symptoms of dementia are distressing for patients and are frequently treated with second-generation antipsychotics. Concerns about the drugs' safety resulted in a Medicines and Healthcare Products Regulatory Agency (MHRA) warning against their use in March 2009.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research